All Clinical Trials
View all active clinical trials around the US.
SparkCures Verified Accurate, up-to-date information. Learn more
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPYPropylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation B...
EVOMELA® COMBINATION CONDITIONING THERAPYPre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With...
PRE AND POST TRANSPLANT ELRANATAMABPhase II Randomized Trial of Population PK Dosed Melphalan With Interleukin-6 Blockade With Siltuximab Vesr...
MELPHALAN WITH OR WITHOUT SILTUXIMABHigh Dose Ascorbic Acid for Plasma Cell Disorders
HIGH-DOSE ASCORBIC ACIDHigh Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
HIGH DOSE ASCORBIC ACID W/ MELPHALAN
Untreated / Newly Diagnosed Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With...
PRE AND POST TRANSPLANT ELRANATAMABPhase II Randomized Trial of Population PK Dosed Melphalan With Interleukin-6 Blockade With Siltuximab Vesr...
MELPHALAN WITH OR WITHOUT SILTUXIMAB
Early Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
SparkCures Verified Accurate, up-to-date information. Learn more
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPYPhase II Randomized Trial of Population PK Dosed Melphalan With Interleukin-6 Blockade With Siltuximab Vesr...
MELPHALAN WITH OR WITHOUT SILTUXIMAB
Late Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPYHigh Dose Ascorbic Acid for Plasma Cell Disorders
HIGH-DOSE ASCORBIC ACIDHigh Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
HIGH DOSE ASCORBIC ACID W/ MELPHALAN
Smoldering Myeloma
No active clinical trials
Monoclonal Gammopathy of Undetermined Significance (MGUS)
No active clinical trials